Paul Hayes was a pack-a-day smoker for more than 30 years. Today he’s a test subject, an ideal candidate for a human drug trial aimed at preventing lung cancer before the deadly disease sets in. His part in the trial began six months ago. He was required to take a drug called Enzastaurin, which may well be capable of changing the way a cell performs. [Dr. Gerold Bepler, Moffit Cancer Center]: “The drug targets a pathway in cells that basically works like a switch, so that a cell when it …
Categories
Recommended
Archives
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- July 2008
Recent Search Terms